Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy

OBJECTIVE: Roux-en-Y gastric bypass (RYGB) produces more durable glycemic control than sleeve gastrectomy (SG) or intensive medical therapy (IMT). However, the contribution of acylated ghrelin (AG), a gluco-regulatory/appetite hormone, to improve glucose metabolism and body composition in patients w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Obes (Lond)
Autors principals: Malin, SK, Samat, A, Wolski, K, Abood, B, Pothier, CE, Bhatt, DL, Nissen, S, Brethauer, SA, Schauer, PR, Kirwan, JP, Kashyap, SR
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4461212/
https://ncbi.nlm.nih.gov/pubmed/24166065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ijo.2013.196
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars